About Us
Focused on Drug Development for Neurodegenerative Diseases
About LysoX
A Lysosome-Targeting Innovative Startup Dedicated to Neurodegenerative Disease Drug Development
Zhejiang Rongmei Biomedical Technology Co., Ltd. is a startup dedicated to tackling neurodegenerative diseases and other lysosomal function deficiency diseases, aiming to become a global leader in novel lysosomal ion channel and transporter-targeted drugs. Founded in 2024 in Hangzhou Future Science and Technology City, the company has received recognition from multiple domestic investment institutions and policy support from Zhejiang Province and Yuhang District government.
Competitive Advantages
Founder
Xu Haoxin
ProfessorDean of School of Basic Medical Sciences, Zhejiang University
Qiushi Chair Professor, Zhejiang University
Professor, Liangzhu Laboratory, Zhejiang University
Presidential Early Career Award for Scientists and Engineers (PECASE)
University of Michigan Distinguished Professor Award
Pioneer of Lysosomal Patch-Clamp Technology
For more research projects and publications, visit www.hxulab.org
Management Team
Our management team brings together talents from all sides. The executive directors of the board control the company's development direction with rich industry experience and strategic vision. Founders Dr. Xu Haoxin and Yao Naxin lay the foundation for the company's development with profound professional knowledge and innovative spirit.
Collaborative Team
For the future, win-win cooperation, continuous innovation, delivering world-leading drugs to patients.